Home » Generex Submits Oral Insulin Phase III Trial Dossier to Indian Government
Generex Submits Oral Insulin Phase III Trial Dossier to Indian Government
Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin “Generex Oral-lyn” to the Indian government for approval.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May